Foghorn Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Foghorn Therapeutics's balance sheet done over the years? Its assets were worth $285,916,000 last year, which is less than in the previous period. 127% of Foghorn Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $363,106,000, which means an decrease by -10% compared compared to last year.

Debt to Assets

Foghorn Therapeutics Inc. (NASDAQ:FHTX): Debt to assets
2018 43058000 82.33M 191.21%
2019 22342000 110.35M 493.95%
2020 255594000 109.40M 42.8%
2021 519774000 422.90M 81.36%
2022 404883000 404.77M 99.97%
2023 285916000 363.10M 127%

FHTX Balance Sheet (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
80.33M345.79M101.13M92.79M14.98M40.01M
Short term investments
153.72M293.58M53.15M92.97M00
Net receivables
00300M000
Inventory
000000
Other current assets
6.12M5.60M5.27M4.91M1.36M383K
Total current assets
240.18M345.79M459.56M190.68M16.88M40.40M
Non-current assets:
Property, Plant and Equipment
42.91M49.39M56.07M62.33M3.71M2.09M
Goodwill
000000
Intangible assets
000000
Long term investments
01.70M1.73M1.73M1.73M0
Other non-current assets
2.82M7.98M2.4M842K11K566K
Total non-current assets
45.73M59.08M60.21M64.90M5.45M2.65M
Total assets
285.91M404.88M519.77M255.59M22.34M43.05M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
34.55M336.82M28.31M2.02M3.25M0
Short term debt
17.03M5.97M6.99M3.98M5.51M0
Total current liabilities
58.43M336.82M48.69M18.84M12.65M3.45M
Non-current liabilities:
Long term debt
36.55M45.53M51.33M78.01M11.11M7.02M
Deferred tax
000000
Other non-current liabilities
0-281.58M143K-19.65M86.58M71.84M
Total non-current liabilities
304.67M67.95M374.21M90.56M97.70M78.87M
Total liabilities
363.10M404.77M422.90M109.40M110.35M82.33M
Data sourceData sourceData sourceData source